【24h】

Ultrasonography and fluoroscopy-guided insertion of chest ports.

机译:超声检查和透视引导下插入胸腔。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: To evaluate the results of ultrasonography and fluoroscopy-guided percutaneous placement of internal jugular vein catheters and subcutaneous chest port system in patients with carcinoma. METHODS: The data of 1418 patients in whom the devices were implanted from 2003 to 2007 in interventional radiology unit were evaluated prospectively. RESULTS: The median age was 45 years (range 23-70), 658 were women and 760 were men. Technical success in implanting the devices was 100%. No instances of major complications such as pneumothorax, hemothorax, catheter tip malposition, air embolism were seen. The overall complication rate was 5%. Overall follow-up of patients was 699 074 catheter days with the mean function time of 493 (range 130-1215) days. CONCLUSIONS: With the benefit of ultrasonography and fluoroscopy guidance, chest port systems can be implanted by interventional radiologists without major insertion complications and with a higher success rate than those reported in surgical placements.
机译:目的:评价超声检查和透视引导下经皮穿刺颈内静脉导管和皮下胸腔系统的置入结果。方法:前瞻性评估2003年至2007年在介入放射科中植入该装置的1418例患者的数据。结果:中位年龄为45岁(范围23-70岁),女性658名,男性760名。植入设备的技术成功率为100%。没有发现重大并发症,例如气胸,血胸,导管尖端位置不正确,空气栓塞。总体并发症发生率为5%。患者的总体随访为699074导管天,平均功能时间为493天(范围130-1215)。结论:借助超声检查和透视检查的指导,介入放射科医师可以植入胸腔系统,而无重大插入并发症,并且成功率高于外科手术报道的成功率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号